ceftriaxone (Kamron Laboratories)

KAMCEF is a brand name representing third-generation cephalosporin antibiotics, primarily ceftriaxone (for injectable formulations) and cefixime (for oral formulations). Developed and manufactured as a commercial generic product by companies including Kamron Laboratories, KAMCEF is indicated for the treatment of moderate-to-severe bacterial infections, including respiratory tract infections, urinary tract infections, meningitis, septicemia, bone and joint infections, and gonorrhea. Ceftriaxone works by binding to and inhibiting penicillin-binding proteins (PBPs), which are essential enzymes involved in the synthesis of the bacterial peptidoglycan cell wall. This inhibition leads to cell wall instability, autolysis, and cell death of susceptible Gram-positive and Gram-negative bacteria.

Brand names

CamcefKAMCEFKAMCEF INJECTION

Other names

cefiximeceftriaxone sodium